Surgical Innovations Group has expressed confidence in its forward order book, citing persistent demand in the UK for its surgery technology. Despite industrial action and a slower pace of evaluations, the company remains optimistic about its long-term growth trajectory. While it has yet to provide any financial forecasts for 2023, Surgical Innovations Group expects to continue trading profitably and investing in operations.
The provider of surgery technology is making headway with two of its three product groups certified by medical regulators; the third is undergoing its final stage. However, supply-chain issues have led to longer lead times for some key product lines, resulting in longer manufacturing times and higher inventory levels. The company plans to manage this by maintaining higher inventory levels than normal and expects the issue to improve in the second half of the year.
Surgical Innovations Group will release its first-half results later this year, in September.
Stay ahead of the latest developments within the surgical technology landscape by following Surgical Innovations Group.
